Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) insider Jeffrey C. Kunins sold 1,035 shares of the business's stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the sale, the insider now owns 124,243 shares of the company's stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
NASDAQ AXON traded down $7.45 on Thursday, hitting $623.80. The stock had a trading volume of 525,778 shares, compared to its average volume of 613,006. The firm has a 50-day moving average of $571.10 and a 200-day moving average of $424.92. The company has a market capitalization of $47.57 billion, a price-to-earnings ratio of 161.19, a price-to-earnings-growth ratio of 14.19 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52-week low of $241.72 and a 52-week high of $698.67.
A number of research firms have recently weighed in on AXON. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Needham & Company LLC increased their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a report on Friday, November 8th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a report on Wednesday, October 23rd. Finally, Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research report on Monday, November 11th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has an average rating of "Moderate Buy" and an average target price of $488.67.
Read Our Latest Report on Axon Enterprise
Large investors have recently added to or reduced their stakes in the business. Quent Capital LLC boosted its position in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company's stock valued at $32,000 after acquiring an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC grew its stake in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after buying an additional 44 shares in the last quarter. Brooklyn Investment Group bought a new position in shares of Axon Enterprise in the 3rd quarter worth $41,000. Asset Dedication LLC bought a new position in shares of Axon Enterprise in the 2nd quarter worth $47,000. Finally, Planning Capital Management Corp raised its position in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company's stock valued at $48,000 after buying an additional 55 shares in the last quarter. Institutional investors own 79.08% of the company's stock.
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.